Aarkstore -Partial Seizure-Pipeline Insights, 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore -Partial Seizure-Pipeline Insights, 2014

Description:

DelveInsights, Partial Seizure-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Partial Seizure. – PowerPoint PPT presentation

Number of Views:20

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore -Partial Seizure-Pipeline Insights, 2014


1
Partial Seizure-Pipeline Insights, 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/healthcare/77317/-partial
    -seizure-pipeline-insights-2014

2
Summary
  • DelveInsights, Partial Seizure-Pipeline Insights,
    2014, report provides comprehensive insights
    about pipeline drugs across this indication. A
    key objective of the report is to establish the
    understanding for all the pipeline drugs that
    fall under Partial Seizure. This report provides
    information on the therapeutic development based
    on the Partial Seizure dealing with all the
    pipeline drugs, comparative analysis at various
    stages covering Filed, Phase III, Phase II, Phase
    I, IND filed, Preclinical, Discovery and unknown
    stages, therapeutics assessment by monotherapy
    and combination products and molecule type drug
    information. The report also covers the companies
    information involved in the therapeutic
    development of the products. It also has
    highlighted the discontinued and dormant products.

3
Summary
  • Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts. Secondary
    sources information and data has been collected
    from various printable and non-printable sources
    like search engines, News websites, Government
    Websites, Trade Journals, White papers,
    Magazines, Trade associations, Books, Industry
    Portals, Industry Associations and access to
    available databases. Note This report requires
    certain updates. We have all the information
    available but require 3 business days to complete
    the process and ensure it is as up-to-date as
    possible. Certain sections in the report may be
    removed or altered based on the availability and
    relevance of data for the indicated Indication.

4
Summary
  • Scope 
  • The report provides a snapshot of the global
    therapeutic landscape of Partial Seizure The
    report provides pipeline products under drug
    profile section which includes product
    description, MOA, licensors collaborators,
    development partner and chemical
    information Coverage of the Partial Seizure
    pipeline on the basis of target, MOA, route of
    administration, technology involved and molecule
    type The report reviews key players involved in
    the therapeutics development for Partial Seizure
    and also provide company profiling The report
    also gives the information of dormant and
    discontinued pipeline projects  Pipeline products
    coverage based on various stages of development
    ranging from preregistration till discovery and
    undisclosed stages  Provides pipeline assessment
    by monotherapy and combination therapy products,
    stage of development and molecule type

5
Summary
  • Reasons to buy Complete Pipeline intelligence
    and complete understanding over therapeutics
    development for Partial Seizure
  • Identify the relationship between the drugs and
    use it for target finding, drug repurposing, and
    precision medicine.
  • Devise corrective measures for pipeline projects
    by understanding Partial Seizure pipeline depth
    and focus of Indication therapeutics
  • Developing strategic initiatives to support your
    drug development activities.
  • Optimize your portfolio and keep you in touch
    with the rapidly changing pharmaceutical markets,
    and make the best decisions for your business.

6
Summary
  • Develop and design in licensing and out licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope
  • Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies
  • Modify the therapeutic portfolio by identifying
    discontinued projects and understanding the
    factors that drove them from pipeline
  • Gaining a Full Picture of the Competitive
    Landscape for Evidence based Decisions

7
Table of Content
  • Partial Seizure Overview Partial Seizure Pipeline
    Therapeutics Partial Seizure Therapeutics under
    Development by Companies  Partial Seizure Late
    Stage Products (Filed and Phase III) Comparative
    Analysis  Partial Seizure Mid Clinical Stage
    Products (Phase II) Comparative Analysis  Partial
    Seizure Early Clinical Stage Products (Phase I
    and IND Filed) Comparative Analysis  Partial
    Seizure Discovery and Pre-Clinical Stage
    Products  Comparative Analysis  Drug Candidate
    Profiles

8
Table of Content
  • Partial Seizure Therapeutics Assessment  Assessmen
    t by Monotherapy Products  Assessment by
    Combination Products  Assessment by Route of
    Administration  Assessment by Molecule
    Type  Partial Seizure Discontinued
    Products  Partial Seizure Dormant
    Products Companies Involved in Therapeutics
    Development for Partial Seizure  Appendix  Methodo
    logy  Contact Us  Disclaimer

9
List of Tables
  • Number of Products under Development for Partial
    Seizure, 2014 Number of Products under
    Development by Companies  Comparative Analysis by
    Late Clinical Stage Products (Filed and Phase
    III), 2014 Comparative Analysis Mid Clinical
    Stage Products (Phase II), 2014 Comparative
    Analysis Early Clinical Stage Products (Phase I
    and IND Filed), 2014 Comparative Analysis
    Discovery and Pre-Clinical Stage Products,
    2014 Drug Candidates Profiles Partial Seizure
    Assessment by Monotherapy Products  Partial
    Seizure Assessment by Combination
    Products  Partial Seizure Assessment by Route of
    Administration 

10
List of Tables
  • Partial Seizure Assessment by Stage and Route of
    Administration  Partial Seizure Assessment by
    Molecule Type  Partial Seizure Assessment by
    Stage and Molecule Type  Partial Seizure
    Therapeutics Discontinued Products  Partial
    Seizure Therapeutics Dormant Products Products
    under Development by Companies, 2014

11
List of Figures
  • Number of Products under Development for Partial
    Seizure, 2014 Late Clinical Stage Products (Filed
    and Phase III), 2014 Mid Clinical Stage Products
    (Phase II), 2014 Early Clinical Stage Products
    (Phase I and IND Filed), 2014 Discovery and
    Pre-Clinical Stage Products, 2014 Partial Seizure
    Assessment by Monotherapy Products  Partial
    Seizure Assessment by Combination
    Products  Partial Seizure Assessment by Route of
    Administration  Partial Seizure Assessment by
    Stage and Route of Administration  Partial
    Seizure Assessment by Molecule Type  Partial
    Seizure Assessment by Stage and Molecule Type

12
Related Reports
  • Laboratory Information Management Systems/ LIMS
    Market by Product (COTS Legacy), Delivery Mode
    (On-premise, Hosted, Cloud), Component (Software
    Services), End User Industries (Healthcare,
    CRO, Petrochemical, Oil and Gas, Chemical) -
    Forecast to 2019
  • 2015 Worldwide Nursing Care Facilities
    Industry-Industry Market Report
  • 2015 Worldwide Medical Surgical Hospitals
    Industry-Industry Market Report
  • 2015 Worldwide Home Health Care Services
    Industry-Industry Market Report
  • 2015 Worldwide Offices of Dentists
    Industry-Industry Market Report
  • Ascension Health - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Accretive Health, Inc. (ACHI) - Strategic SWOT
    Analysis Review

13
  • Partial Seizure-Pipeline Insights, 2014
  • Published Dec. 2014 60 Pages
  • DelveInsights, Partial Seizure-Pipeline Insights,
    2014, report provides comprehensive insights
    about pipeline drugs across this indication.
    Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor, B-Wing,
Mahaavir Icon,  Plot No.- 89 90,
Sector-15, CBD-Belapur, Navi Mumbai
400614,  Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com